Clinical Trial Technology Editorial

  1. Evolving Neurology And Neuroinflammation Therapies And Trials In 2025 6/5/2025

    Could 2025 be the year that advancements in brain health and increased funding for innovative therapies make a difference for neuroinflammation therapies and trials? Immunic CEO Daniel Vitt, Ph.D., discusses.

  2. In The Age Of AI, Data Is Still King 5/29/2025

    While AI captures attention, data quietly runs the show, says Empactful Ventures Founder Denise Bronner, Ph.D. She explains why proprietary data sets are the foundation of everything AI promises to deliver.

  3. What's The Risk Of Letting Researchers Use LLMs? 5/21/2025

    Who should be using AI and how? Sage Therapeutics' Jake Alme explores AI use in clinical research, examining its use shifting toward more complex applications and discussing the risk of using it in the public domain.

  4. Refresh Your CTA Strategy With Cybersecurity And EHRs In Mind, Part One 5/19/2025

    Leibowitz Law experts examine how tech developments affect key CTA provisions and provide practical, technology-inspired updates for your clinical trial agreements. Part one of this two-part series explores cybersecurity and EHR standards. 

  5. How AI And Secondary Data Use Are Changing The Way We Do CTAs, Part Two 5/19/2025

    Leibowitz Law experts examine how tech developments affect key CTA provisions and provide practical, technology-inspired updates for your clinical trial agreements. Part two covers the secondary use of study data and AI.

  6. Are Sites Even Using AI?: How Sponsors And CROs Can Support Uptake 5/16/2025

    How much are clinical research sites using AI? And how can sponsors and CROs effectively support sites in doing so? Consultant Maria P. Ladd explains.

  7. 5 Ways AI Is Changing Clinical Research — And How To Embrace It 5/15/2025

    Discover how AI is transforming clinical trials, learn real tools already in use, and get practical guidance for clinical professionals — especially CRAs and site teams — looking to upskill in an AI-enhanced environment.

  8. How Recursion Is Industrializing Clinical Trials With AI 5/12/2025

    Recursion SVP of Clinical Development and Data Science Sid Jain discusses the company's three-point "ClinTech" strategy, focusing on AI-assisted trial design, trial execution, and evidence generation.

  9. The Risk And Reward Of Clinical Investigators Integrating AI 5/1/2025

    Husch Blackwell LLP experts discuss relevant regulatory frameworks and the risks and liabilities of clinical investigators using AI.

  10. Track Your Trial's Carbon Footprint With This Sustainability Calculator 4/24/2025

    Pistoia Alliance Portfolio Lead Thierry Escudier discusses the latest updates to the Clinical Trial Carbon Calculator.